Kundl, Austria

Christoph Bitter


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Bitter: Innovator in Penicillin Delivery Systems

Introduction

Christoph Bitter, an accomplished inventor based in Kundl, Austria, has made significant contributions to the field of pharmaceutical innovations. With a focus on enhancing drug delivery systems, his work is particularly noteworthy in the area of penicillin formulations for intramuscular injections.

Latest Patents

Christoph Bitter holds a patent for a breakthrough in injectables titled "Penicillin retard composition for intramuscular injection." This inventive syringe design is centered around a composition that includes penicillin, a salt or prodrug of penicillin, along with several pharmaceutically acceptable excipients and water. Notably, the composition is free of any preservative agents, which enhances safety and efficacy. Additionally, the patent discusses the production process of this injection syringe and includes a kit that contains it.

Career Highlights

Christoph Bitter is an integral part of Sandoz AG, a prominent company known for its commitment to quality pharmaceuticals. His role at Sandoz highlights his dedication to advancing medical technology and improving patient outcomes through innovative drug delivery techniques.

Collaborations

Throughout his career, Christoph has had the opportunity to collaborate with several talented professionals, including Heiko Degendorfer and Johannes Raneburger. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

In summary, Christoph Bitter stands out as a significant figure in pharmaceutical innovations, particularly with his patent for a penicillin injection composition. His contributions not only reflect his expertise but also illustrate the collaborative spirit essential to advancing healthcare solutions. As he continues to work at Sandoz AG, the impact of his inventions is likely to benefit the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…